Saturday 17 October 2026 Export XLO’s income statement to Excel — free account

Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $43.8 million, up 589.9% from fiscal 2024. In the quarter to June 2026, revenue grew 131.2%, EPS grew 85.3% and free cash flow fell 26.2%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

8.77 0.25 −2.77%

Follow XLO

Alert me

Market cap: $59.4M
P/E: 0.0×
Fwd P/E: −2.6×
Dividend yield: —
F-score: n/a
Altman Z: −3.34
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(55.03%)	(75.20%)	(132.53%)	(908.28%)	+8 more TTM periods Free account
ROA Full definition →	(15.16%)	(23.43%)	(31.04%)	(56.14%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(19.04%)	(27.23%)	(37.82%)	(81.96%)
Average Days of Receivables Full definition →	34.17	0.00	41.70	200.84
Free Cash Flow per Share Full definition →	(3.16)	(3.51)	(0.66)	(1.71)
Free Cash Flow Full definition →	(61.27)	(57.36)	(5.51)	(17.58)
Capital Expenditures Full definition →	(0.67)	(1.05)	(0.52)	(0.43)
Other line items
Cash ROIC Full definition →	(29.41%)	(25.74%)	(3.19%)	(18.38%)
Accounts Receivable Turnover Full definition →	0.00	0.00	0.00	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	104.28%	126.40%	128.04%	147.00%
Selling, General and Administrative Expense of Revenue Full definition →	44.66%	52.58%	67.88%	90.64%
Share Based Compensation of Revenue Full definition →	12.27%	14.24%	15.85%	17.37%
Operating CF/Net income Full definition →	2.78	1.80	0.14	0.29
Depreciation/Fixed assets Full definition →	0.40	0.38	0.40	0.43
Capex/Depreciation Full definition →	(0.50)	(0.76)	(0.34)	(0.27)
Revenue per Share Full definition →	3.30	3.27	5.24	3.09
Operating CF per Share Full definition →	(3.12)	(3.44)	(0.60)	(1.67)
Capex per Share Full definition →	(0.03)	(0.06)	(0.06)	(0.04)
Capex to Sales Full definition →	0.01	0.02	0.01	0.01

Show all line items

Columns are period end dates

Stockrow Weekly